AGP Executive Report
Last update: 7 hours agoHemp Rules: A federal restriction on cannabinoids that cannot naturally occur in cannabis, including THC-O, takes effect Nov. 12. Affected products may face controlled-substance restrictions, while broader hemp-rule changes are delayed until Dec. 11, leaving sellers uncertain. Pain Care: Data from 3,744 UK medical-cannabis patients found sustained improvements in pain, sleep, anxiety and quality of life over two years; 23% of patients using opioids at the outset achieved a meaningful reduction. Industry Finance: Cannabinoid-focused Avicanna closed a $2 million financing deal to support product development, commercialization and operations.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.